A discussion on the role of the cabozantinib and nivolumab regimen in the treatment of advanced RCC.
Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice
Drs Alter and Diamond muse about the unmet needs in advanced RCC treatment.
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
3
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5